Abstract:Chronic arsenic exposure is a global health hazard significantly associated with the development of deleterious cutaneous changes and increased keratinocyte cancer risk. Although arsenic exposure is associated with broad-scale cellular and molecular changes, gaps exist in understanding how these changes impact the skin and facilitate malignant transformation. Recently developed epigenetic "clocks" can accurately predict chronological, biological and mitotic age, as well as telomere length, on the basis of tissue DNA methylation state. Deviations of predicted from expected age (epigenetic age dysregulation) have been associated with numerous complex diseases, increased all-cause mortality and higher cancer risk. We investigated the ability of these algorithms to detect molecular changes associated with chronic arsenic exposure in the context of associated skin lesions. To accomplish this, we utilized a multi-algorithmic approach incorporating seven "clocks" ( Horvath, Skin&Blood, PhenoAge, PCPhenoAge, GrimAge, DNAmTL and epiTOC2 ) to analyze peripheral blood of pediatric and adult cohorts of arsenic-exposed (n = 84) and arsenic-naïve (n = 33) individuals, among whom n = 18 were affected by skin lesions. Arsenic-exposed adults with skin lesions exhibited accelerated epigenetic ( Skin&Blood : + 7.0 years [95% CI 3.7; 10.2], q = 6.8 × 10 –4 ), biological ( PhenoAge: + 5.8 years [95% CI 0.7; 11.0], q = 7.4 × 10 –2 , p = 2.8 × 10 –2 ) and mitotic age ( epiTOC2: + 19.7 annual cell divisions [95% CI 1.8; 37.7], q = 7.4 × 10 –2 , p = 3.2 × 10 –2 ) compared to healthy arsenic-naïve individuals; and accelerated epigenetic age ( Skin&Blood: + 2.8 years [95% CI 0.2; 5.3], q = 2.4 × 10 –1 , p = 3.4 × 10 –2 ) compared to lesion-free arsenic-exposed individuals. Moreover, lesion-free exposed adults exhibited accelerated Skin&Blood age (+ 4.2 [95% CI 1.3; 7.1], q = 3.8 × 10 –2 ) compared to their arsenic-naïve counterparts. Compared to the pediatric group, arsenic-exposed adults exhibited accelerated epigenetic (+ 3.1 to 4.4 years (95% CI 1.2; 6.4], q = 2.4 × 10 –4 –3.1 × 10 –3 ), biological (+ 7.4 to 7.8 years [95% CI 3.0; 12.1] q = 1.6 × 10 –3 –2.8 × 10 –3 ) and mitotic age (+ 50.0 annual cell divisions [95% CI 15.6; 84.5], q = 7.8 × 10 –3 ), as well as shortened telomere length (− 0.23 kilobases [95% CI − 0.13; − 0.33], q = 2.4 × 10 –4 ), across all seven algorithms. We demonstrate that lifetime arsenic exposure and presence of arsenic-associated skin lesions are associated with accelerated epigenetic, biological and mitotic age, and shortened telomere length, reflecting altered immune signaling and genomic regulation. Our findings highlight the usefulness of DNA methylation-based algorithms in identifying deleterious molecular changes associated with chronic exposure to the heavy metal, serving as potential prognosticators of arsenic-induced cutaneous malignancy.

Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood

Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype

Effect of Long-Term Low-Dose Arsenic Exposure on DNA Methylation and Gene Expression in Human Liver Cells

Roles of Serum Uric Acid on the Association Between Arsenic Exposure and Incident Metabolic Syndrome in an Older Chinese Population

Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease

Exposure to arsenic at different life-stages and DNA methylation meta-analysis in buccal cells and leukocytes

Identification of Novel Gene Targets and Putative Regulators of Arsenic-Associated DNA Methylation in Human Urothelial Cells and Bladder Cancer

Targeting the 'DNA methylation mark': Analysis of early epigenetic-alterations in children chronically exposed to arsenic

Low-level environmental cadmium exposure is associated with DNA hypomethylation in Argentinean women

Environmental Arsenic Exposure and Human Health Risk

Inherited genetic effects on arsenic metabolism: A comparison of effects on arsenic species measured in urine and in blood

Integrating SNPs-based genetic risk factor with blood epigenomic response of differentially arsenic-exposed rural subjects reveals disease-associated signaling pathways

Genome-wide DNA methylation pattern in whole blood of patients with coal-burning arsenic poisoning

The impact of prenatal and early-life arsenic exposure on epigenetic age acceleration among adults in Northern Chile

Factors Affecting Arsenic Methylation in Arsenic-Exposed Humans: A Systematic Review and Meta-Analysis

Arsenic Exposure from Drinking Water Disrupts Hepatic DNA Integrity and Alters Energy Metabolism in Lymphocytes and Brain Tissue

Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions

Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, selectively induced by chronic arsenic exposure, is associated with extent of arsenic-related skin lesions.

Transgenerational effects in DNA methylation, genotoxicity and reproductive phenotype by chronic arsenic exposure

Arsenic Methylation Capacity and Metabolic Syndrome in the 2013–2014 U.S. National Health and Nutrition Examination Survey (NHANES)

Epigenetic mechanisms underlying the toxic effects associated with arsenic exposure and the development of diabetes